Contribution of the ELFG Test in Algorithms of Non-Invasive Markers towards the Diagnosis of Significant Fibrosis in Chronic Hepatitis C

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zarski, Jean Pierre ^a,b   Sturm, Nathalie ^a,b   Guechot, Jérôme ^c   Zafrani, Elie Serge ^d   Vaubourdolle, Michel ^c   Thoret, Sophie ^a   Margier, Jennifer ^a   David Tchouda, Sandra ^a   Bosson, Jean Luc ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; HYALURONIC ACID; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALGORITHM; APRI SCORE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELFG TEST; FIBROMETER; FIBROSCAN; FIBROTEST; FORNS SCORE; HEPASCORE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MP3 SCORE; PREDICTIVE VALUE; REVIEW; SCORING SYSTEM;

ALGORITHMS; BIOLOGICAL MARKERS; BIOPSY; ELASTICITY IMAGING TECHNIQUES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; PRINCIPAL COMPONENT ANALYSIS;

EID: 84875318262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059088     Document Type: Review

References (24)

1. Adams L, Bulsara M, Rossi E, DeBoer B, Speers D, et al. (2005) Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51: 1867-1873.
2. Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet M-C, et al. (2005) A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42: 1373-1381.
3. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, et al. (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357: 1069-1075.
4. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, et al. (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41: 48-54.
5. Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, et al. (2005) Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 53: 1013-1021.
6. Haute Autorité de Santé (HAS) France (2006) Methods of Assessment of Hepatic Fibrosis during chronic liver disease [Méthodes d'évaluation de la fibrose hépatique au cours des hépatopathies chroniques] Available: http://www.hassante.fr/portail/upload/docs/application/pdf/rapport_fibrose.pdf.
7. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, et al. (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection, comparison with liver biopsy and fibrotest. Hepatology 46: 32-36.
8. Forns X, Ampurdanes S, Llovet J, Aponte J, Quintó L, et al. (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36: 986-992.
9. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, et al. (2005) Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99: 271-279.
10. Wai CT, Greenson J, Fontana RJ, Kalbfleisch JD, Marrero JA, et al. (2005) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526.
11. Rosenberg W, Voelker M, Thiel R, Burt A, Schuppan D, et al. (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127: 1704-1713.
12. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, et al. (1996) Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 42: 558-563.
13. Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, et al. (2012) Comparison of 9 blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 56: 55-62.
14. Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, et al. (2006) Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 44: 686-693.
15. Sebastiani G, (2009) Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol 15: 2190-203.
16. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343-350.
17. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, et al. (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51: 828-835.
18. Tsutsumi M, Takase S, Urashima S, Ueshima Y, Kawahara H, et al. (1996) Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Alcoholism: Clinical and Experimental Research 20: 1512-1517.
19. Lucidarme D, Foucher J, Le Bail B, Vergniol J, Castera L, et al. (2009) Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 49: 1083-1089.
20. Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco D, et al. (2012) Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther 35: 92-104.
21. Quinlan JR (1993) C4.5: Programs for machine learning, Morgan Kaufmann, San Mateo, CA.
22. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, et al. (2006) Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 13: 659-670.
23. Bedossa P, Dargere D, Paradis V, (2003) Sampling variability of liver fibrosis in chronic hepatitis C,. Hepatology 38: 1449-1457.
24. Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, et al. (2008) Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 8: 1-8.